Literature DB >> 19801173

Genome integrity: linking pluripotency and tumorgenicity.

Wenbin Deng1, Yang Xu.   

Abstract

Genome integrity is a fundamental issue in both cancer and stem cell biology. A series of recent studies revealed that a tumor suppressor p53, which is required for genome integrity, is critical also for stem cell pluripotency and reprogramming, further strengthening the fundamental link between cancer and pluripotency. p53 and other tumor suppressors might be barriers to reprogramming somatic cells for the generation of induced pluripotent stem cells (iPSCs), and simultaneously and systematically destroying these barriers would improve reprogramming efficiency. Therefore, it is also crucial to determine the tumorgenicity of the cells derived from iPSCs for any future therapeutic use.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801173      PMCID: PMC2789921          DOI: 10.1016/j.tig.2009.09.004

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  12 in total

1.  p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression.

Authors:  Tongxiang Lin; Connie Chao; Shin'ichi Saito; Sharlyn J Mazur; Maureen E Murphy; Ettore Appella; Yang Xu
Journal:  Nat Cell Biol       Date:  2004-12-26       Impact factor: 28.824

Review 2.  Reprogramming somatic cells towards pluripotency by defined factors.

Authors:  Marc Lewitzky; Shinya Yamanaka
Journal:  Curr Opin Biotechnol       Date:  2007-10       Impact factor: 9.740

3.  A combined chemical and genetic approach for the generation of induced pluripotent stem cells.

Authors:  Yan Shi; Jeong Tae Do; Caroline Desponts; Heung Sik Hahm; Hans R Schöler; Sheng Ding
Journal:  Cell Stem Cell       Date:  2008-06-05       Impact factor: 24.633

4.  Two supporting factors greatly improve the efficiency of human iPSC generation.

Authors:  Yang Zhao; Xiaolei Yin; Han Qin; Fangfang Zhu; Haisong Liu; Weifeng Yang; Qiang Zhang; Chengang Xiang; Pingping Hou; Zhihua Song; Yanxia Liu; Jun Yong; Pengbo Zhang; Jun Cai; Meng Liu; Honggang Li; Yanqin Li; Xiuxia Qu; Kai Cui; Weiqi Zhang; Tingting Xiang; Yetao Wu; Yiding Zhao; Chun Liu; Chen Yu; Kehu Yuan; Jinning Lou; Mingxiao Ding; Hongkui Deng
Journal:  Cell Stem Cell       Date:  2008-11-06       Impact factor: 24.633

5.  A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity.

Authors:  Rosa M Marión; Katerina Strati; Han Li; Matilde Murga; Raquel Blanco; Sagrario Ortega; Oscar Fernandez-Capetillo; Manuel Serrano; Maria A Blasco
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

6.  The Ink4/Arf locus is a barrier for iPS cell reprogramming.

Authors:  Han Li; Manuel Collado; Aranzazu Villasante; Katerina Strati; Sagrario Ortega; Marta Cañamero; Maria A Blasco; Manuel Serrano
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

7.  Immortalization eliminates a roadblock during cellular reprogramming into iPS cells.

Authors:  Jochen Utikal; Jose M Polo; Matthias Stadtfeld; Nimet Maherali; Warakorn Kulalert; Ryan M Walsh; Adam Khalil; James G Rheinwald; Konrad Hochedlinger
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

Review 8.  The p53 pathway.

Authors:  C Prives; P A Hall
Journal:  J Pathol       Date:  1999-01       Impact factor: 7.996

9.  Linking the p53 tumour suppressor pathway to somatic cell reprogramming.

Authors:  Teruhisa Kawamura; Jotaro Suzuki; Yunyuan V Wang; Sergio Menendez; Laura Batlle Morera; Angel Raya; Geoffrey M Wahl; Juan Carlos Izpisúa Belmonte
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

10.  Senescence impairs successful reprogramming to pluripotent stem cells.

Authors:  Ana Banito; Sheikh T Rashid; Juan Carlos Acosta; SiDe Li; Carlos F Pereira; Imbisaat Geti; Sandra Pinho; Jose C Silva; Veronique Azuara; Martin Walsh; Ludovic Vallier; Jesús Gil
Journal:  Genes Dev       Date:  2009-08-20       Impact factor: 11.361

View more
  11 in total

1.  Induced pluripotent stem cells: paths to new medicines. A catalyst for disease modelling, drug discovery and regenerative therapy.

Authors:  Wenbin Deng
Journal:  EMBO Rep       Date:  2010-02-19       Impact factor: 8.807

2.  Noncoding RNA landmarks of pluripotency and reprogramming.

Authors:  Zhengqing Ouyang; Grace X Y Zheng; Howard Y Chang
Journal:  Cell Stem Cell       Date:  2010-12-03       Impact factor: 24.633

3.  Context-dependent enhancement of induced pluripotent stem cell reprogramming by silencing Puma.

Authors:  Blue B Lake; Jürgen Fink; Liv Klemetsaune; Xuemei Fu; John R Jeffers; Gerard P Zambetti; Yang Xu
Journal:  Stem Cells       Date:  2012-05       Impact factor: 6.277

Review 4.  The reciprocal relationship between primordial germ cells and pluripotent stem cells.

Authors:  Mehdi Pirouz; Alexander Klimke; Michael Kessel
Journal:  J Mol Med (Berl)       Date:  2012-05-15       Impact factor: 4.599

5.  Functional human artificial chromosomes are generated and stably maintained in human embryonic stem cells.

Authors:  Mohammad A Mandegar; Daniela Moralli; Suhail Khoja; Sally Cowley; David Y L Chan; Mohammed Yusuf; Sayandip Mukherjee; Michael P Blundell; Emanuela V Volpi; Adrian J Thrasher; William James; Zoia L Monaco
Journal:  Hum Mol Genet       Date:  2011-05-18       Impact factor: 6.150

6.  Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming.

Authors:  Aaron R Quinlan; Michael J Boland; Mitchell L Leibowitz; Svetlana Shumilina; Sidney M Pehrson; Kristin K Baldwin; Ira M Hall
Journal:  Cell Stem Cell       Date:  2011-10-04       Impact factor: 24.633

7.  Reversible mitochondrial DNA accumulation in nuclei of pluripotent stem cells.

Authors:  Joel S Schneider; Xin Cheng; Qingshi Zhao; Chingiz Underbayev; J Patrick Gonzalez; Elizabeth S Raveche; Diego Fraidenraich; Andreas S Ivessa
Journal:  Stem Cells Dev       Date:  2014-08-04       Impact factor: 3.272

8.  DNA damage responses in human induced pluripotent stem cells and embryonic stem cells.

Authors:  Olga Momcilovic; Leah Knobloch; Jamie Fornsaglio; Sandra Varum; Charles Easley; Gerald Schatten
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

Review 9.  Impact of retrotransposons in pluripotent stem cells.

Authors:  Yoshiaki Tanaka; Leeyup Chung; In-Hyun Park
Journal:  Mol Cells       Date:  2012-11-06       Impact factor: 5.034

10.  Genome stabilization by RAD51-stimulatory compound 1 enhances efficiency of somatic cell nuclear transfer-mediated reprogramming and full-term development of cloned mouse embryos.

Authors:  Ah Reum Lee; Ji-Hoon Park; Sung Han Shim; Kwonho Hong; Hyeonwoo La; Kyung-Soon Park; Dong Ryul Lee
Journal:  Cell Prolif       Date:  2021-05-21       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.